Patients First Act of 2017
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Patients First Act of 2017
This bill amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions, provided that the techniques will not involve: (1) the creation of a human embryo for research purposes; (2) the destruction or discarding of, or risk of injury to, a living human embryo; or (3) the use of any stem cell the derivation or provision of which would be inconsistent with this bill.
HHS must issue guidelines to ensure that any research (including any clinical trial) supported under this bill: (1) is clearly consistent with the standards established in this bill, if conducted using human cells; and (2) is prioritized in terms of potential for near-term clinical benefit in human patients.
HHS must report on peer reviewed stem cell research proposals that were not funded.
Referred to the Subcommittee on Health.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 2918: Patients First Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-2918/
"H.R. 2918: Patients First Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-2918/.
H.R. 2918, 115th Cong. (2026), https://openamerica.io/bill/115-HR-2918/.
[H.R. 2918: Patients First Act of 2017](https://openamerica.io/bill/115-HR-2918/)